WCMNX | YOVIX | WCMNX / YOVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 9 years | - |
Gain YTD | -1.497 | 2.962 | -51% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.2M | 30.4M | 132% |
Annual Yield % from dividends | 0.00 | 0.22 | - |
Returns for 1 year | -1.65 | 6.17 | -27% |
Returns for 3 years | 6.38 | -2.57 | -248% |
Returns for 5 years | 13.84 | 29.45 | 47% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRNZX | 20.86 | -0.07 | -0.33% |
T. Rowe Price International Stock Z | |||
FBDIX | 123.32 | -0.72 | -0.58% |
Franklin Biotechnology Discovery A | |||
EMAAX | 15.02 | -0.16 | -1.05% |
Gabelli Entpr Mergers & Acquisitions A | |||
KCVIX | 17.41 | -0.24 | -1.36% |
Knights of Columbus Large Cap Value I | |||
USGLX | 65.01 | -1.09 | -1.65% |
JHancock U.S. Global Leaders Growth A |